N-(2-Aminoethyl)-4-bromobenzenesulfonamide, 95.0%, 10g

2-Quinolinecarboxamide, N-[2-(4,5-dihydro-2-oxazolyl)phenyl]-, 1g

3-Bromo-3',4'-difluorobenzophenone, 97.0%, 250mg

Lorlatinib, 99.92%, 1g

[2-(2-Hydroxy-ethoxy)-ethyl]-carbamic acid benzylester, 95+%, 10g

Potassium 4-(1H-indol-3-yl)butanoate, 95.0%, 10g

2-Chloro-5-fluorophenetole, 5g

Phthalylsulfathiazole>95.0%(T)25g

2,8-Dimethyl-quinoline-3-carboxylic acid, 95.0%, 1g

2-Chloro-N-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 5g

2,2'-((Oxybis(ethane-2,1-diyl))bis(oxy))diethanol, 95.0%, 1kg

4-Chloro-3-nitrobenzoic acid, 95.0%, 25g

Oxalic acid diimidazolide, 95.0%, 5g